Want to create an interactive transcript for this episode?
Podcast: Dr. Chapa’s OBGYN Clinical Pearls
Episode: Tamoxifen for Nexplanon Bleeding? A New RCT.
Description: LARCS are endorsed by the ACOG due to the high efficacy. However, unpredictable bleeding can affect continuation rates. A new RCT has evaluated the use of tamoxifen to control and prevent future abnormal bleeding with etonogestrel implant use. Does this work? What is the MOA? In this session, we will summarize this new publication (published ahead of print) in Obstetrics and Gynecology.